Effect of long-term co-trimoxazole therapy on renal function

Area of Science:

• Nephrology
• Pharmacology
• Urology

Background:

• Neurogenic bladder dysfunction often requires long-term medication.
• Co-trimoxazole is a common antibiotic prophylaxis for urinary tract infections in these patients.
• Understanding the long-term renal effects of co-trimoxazole is crucial for patient management.

Purpose of the Study:

• To evaluate the impact of prolonged co-trimoxazole administration on renal function.
• To assess changes in creatinine clearance rates in patients with neurogenic bladder.
• To determine if co-trimoxazole causes significant renal impairment in this population.

Main Methods:

• Creatinine clearance rates were measured in 18 patients with neurogenic bladder.
• Patients received prophylactic co-trimoxazole for 60-80 days.
• A subset of seven patients had treatment extended to 330-430 days.

Main Results:

• In the initial group (60-80 days), average creatinine clearance increased from 99.0 ml/min to 110.7 ml/min (P = 0.15).
• In the extended treatment group (330-430 days), average creatinine clearance decreased from 104.4 ml/min to 94.7 ml/min (P > 0.3).
• No statistically significant changes in renal function were observed in either group.

Conclusions:

• Prolonged co-trimoxazole administration appears safe for renal function in patients with baseline creatinine clearance above 50 ml/min.
• Long-term use of co-trimoxazole does not lead to significant renal deterioration in this patient cohort.
• Further studies may be warranted to confirm these findings in diverse patient groups.